NBCA is a synthetic biodegradable cyanoacrylate basis glue, modified by the addition of a monomer with adhesive, hemostatic, and antiseptic properties. Its use requires a steep learning curve to control emulsification of the NBCA/lipiodol mixture, and injection, to avoid non-target embolization. The aim of this retrospective monocentric study was to evaluate safety and efficacy of use of NBCA as embolic agent in emergency setting.
Study Type
OBSERVATIONAL
Enrollment
122
Collecting data from the medical record.
Collecting data from the medical record.
Collecting data from the medical record.
CHU de Saint-Etienne
Saint-Priest-en-Jarez, France
Evaluation of technical success
Analysis of angiographic results.
Time frame: Month : 1
Assessment of clinical success
Disappearance of signs and symptoms of bleeding during the 30 days of follow-up after WT
Time frame: Month : 1
Assessment of clinical success
No endoscopic treatment
Time frame: Month : 1
Assessment of clinical success
No surgical intervention
Time frame: Month : 1
Assessment of clinical success
No repeat WT
Time frame: Month : 1
Assessment of clinical success
Absence of death due to massive blood loss
Time frame: Month : 1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.